Tyloxapol
From Wikipedia, the free encyclopedia
|
Tyloxapol
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | R05 |
| PubChem | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type; used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. Tyloxapol, when injected IP, also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
